← All trials
NCT04345666
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2020
- Primary completion
- Aug 31, 2022
- Completion date
- Jan 31, 2023
- First posted
- Apr 14, 2020
- Last posted
- Apr 14, 2020
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Orthopedic Institute, Sioux Falls, SDLead sponsor
- Orthopedic Institute, Sioux Falls, SDOverall official - principal investigator
- Orthopedic Institute, Sioux Falls, SDReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.